Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Enrico M. Novelli, MD
Healthcare Provider Associate Professor of Medicine
Vascular Medicine Institute
E1257 BST
200 Lothrop Street
Pittsburgh, Pennsylvania, United States
Dr. Novelli obtained his MD degree from the University of Milan, Italy in 1996. He was a postdoctoral fellow at Johns Hopkins University from 1996 to 1999 where he developed expertise in cellular biology and gene therapy. Dr. Novelli’s main areas of interest are sickle cell disease and disorders of hemostasis. Dr. Novelli holds a sickle cell disease and hemoglobinopathy clinic at the Hillman Cancer Center and a hemophilia and thrombosis clinic at the Hemophilia Center of Western Pennsylvania. In addition, he works as a member of the inpatient hematology consult service for several weeks of the year. Another longstanding interest of Dr. Novelli’s is in developing global health research and training initiatives in Tropical Hematology.
Research Interests: One recent interest of Dr. Novelli’s is elucidating the fundamental mechanisms underlying hemolysis-associated thrombosis and vascular dysfunction in SCD. Patients with SCD suffer from severe chronic hemolytic anemia and acute episodes of RBC trapping and destruction in the microvasculature (vaso-occlusive crises). Dr. Novelli’s current research project explores the role of Thrombospondin-1 (TSP1), a glycoprotein abundantly present in platelet α-granules which is emerging as a key regulator of hemostasis and thrombosis.
Representative Publications:
Pulmonary embolism in sickle cell disease: a case-control study
+myBinderRelated Content
-
East Carolina University Comprehensive Sickle Cell CenterEast Carolina University Comprehensive S...
-
High ED Utilization and Perceptions of Opioid Addictionhttps://www.youtube.com/watch?v=9xJ4VwtB...
-
Teens with Sickle Cell Disease Moving from Pediatric Care to Adult CareMoving from pediatric (children’s) car...
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
-
Shelley Crary, MD, MSDr. Shelley Crary received her undergrad...
-
The Sickle Cell Council of New MexicoThe Sickle Cell Council of New Mexico se...
-
Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chroni...Background: We undertook a large multisi...
